Search the Newsreel

Earnings Flash (EYE) National Vision Holdings, Inc. Posts Q2 Adjusted EPS $0.25 per Share, vs. FactSet Est of $0.18

National Vision Holdings, Inc. (EYE) reported adjusted earnings per share of $0.25 for Q2, surpassing FactSet's estimate of $0.18. The company's revenue for the quarter was $498.8 million, slightly below the FactSet estimate of $499.1 million. National Vision also provided its fiscal 2026 outlook, …

National Vision Holdings Reports Q2 2026: Revenue $498.8M, Net Income $12.4M, Adj. Op. Income $31.6M

National Vision Holdings reported strong Q2 2026 results, with net revenue reaching $498.8 million and net income at $12.4 million. The company saw a rise in adjusted operating income to $31.6 million and increased its full-year guidance for this metric, alongside a narrowed outlook …

National Vision (EYE) boosts 2026 profit outlook after Q2 earnings jump

National Vision Holdings, Inc. (EYE) reported strong Q2 2026 results, with net revenue up 2.5% to $498.8 million and net income increasing to $12.4 million. The company raised its fiscal 2026 outlook for Adjusted Operating Income and Adjusted Diluted EPS, reflecting improved profitability driven …

National Vision beats Q2 profit view, raises income outlook

National Vision Holdings, Inc. reported better-than-expected Q2 earnings per share of $0.25, surpassing analyst estimates, though revenue of $498.8 million slightly missed projections. The company raised its full-year adjusted operating income guidance and narrowed its adjusted comparable store sales growth outlook, citing improved profitability …

National Vision Q2 revenue rises to $498.8 million

National Vision adds nine America’s Best stores in Q2

National Vision (EYE) Earnings Date and Reports 2026 $EYE

National Vision Holdings (EYE) Could Be 23% Below Fair Value On Premium Product Mix

National Vision earnings on deck after Q1 beat raised bar

National Vision Holdings Inc. is set to report Q2 earnings, with analysts expecting a sequential decline in EPS and revenue compared to a strong Q1. Investors will be monitoring whether the anticipated Q2 dip is normal seasonality or indicative of deeper challenges to the …

Lotus Eye Hospital net profit rises 13% in Q1FY27 on revenue surge

LUCY Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Shares Higher - Surprise Factor Analysis

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Eyepoint Pharmaceuticals (NASDAQ:EYPT) has received a "Moderate Buy" consensus rating from nine brokerages, with an average 12-month price target of $44.38. Institutional ownership is high at 99.41%, with several major firms recently increasing their stakes. Despite positive analyst sentiment regarding its pipeline, the company …

Hawkeye 360 Inc (HAWK:UN): Stock Price, Quote and News

This article provides a listing for Hawkeye 360 Inc (HAWK:UN), offering information on its stock price, quotes, and related news. It appears to be a placeholder or a link to a company profile page on BNN Bloomberg, as no specific news content is present. …

Mobileye Global Inc. (MBLY) director adds 11,841 shares in open-market buy

Mobileye Global Inc. director Safroadu Yeboah-Amankwah purchased 11,841 shares of Class A Common Stock at $8.46 per share on August 6, 2026. This open-market transaction increased his direct holdings to 84,336 shares of Class A Common Stock. The Form 4 filing details this acquisition, …

Why Kits Eyecare Ltd stock is tanking today

Lotus Eye Hospital and Institute Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Nova Eye Medical (ASX:EYE) Rises As Sales Momentum Improves Earnings Outlook

Innovative Eyewear Inc SEC Filing (Aug 10, 2026)

Innovative Eyewear Inc (NASDAQ: LUCY) filed a Notice of Effectiveness with the SEC on August 10, 2026, for its S-1 registration form, which became effective on August 7, 2026, at 5:00 P.M. The filing impact and sentiment are noted as neutral. The article also …

Trading the Move, Not the Narrative: (EYPT) Edition

This article provides a detailed AI-driven analysis for Eyepoint Pharmaceuticals Inc. (EYPT), highlighting divergent sentiment readings and outlining specific trading strategies for various risk profiles. It identifies key support and resistance levels across multiple timeframes and suggests a significant risk-reward short setup. The analysis …

(EYE) and the Role of Price-Sensitive Allocations

This article provides an AI-generated analysis for National Vision Holdings Inc. (NYSE: EYE), highlighting a strong near and mid-term sentiment but a weak long-term outlook. It details specific trading strategies for different risk profiles, including position, momentum breakout, and risk hedging, along with multi-timeframe …

HC Wainwright Issues Negative Outlook for EYPT Earnings

Defense Stocks Investors Are Watching As Security Spending Comes Back Into Focus

As concerns about political instability and security spending increase, investors are focusing on defense and security stocks. This article highlights three companies – HawkEye 360 (HAWK), Senior (SNR), and Satellogic (SATL) – that are particularly exposed to the current news cycle, each presenting a …

Kits Eyecare Q2 Earnings Call Highlights

EyePoint Pharma nears key Phase III data for DURAVYU in wet AMD, aiming to reduce injection frequency by 2026

EyePoint Pharmaceuticals is awaiting crucial Phase III LUGANO trial results for its wet AMD treatment, DURAVYU, which are expected by August 2026. The trial is designed to show sustained six-month dosing and compares directly to existing standard treatments. EyePoint's strong market position is bolstered …

Janus Henderson Group PLC Has $2.57 Million Holdings in Weyerhaeuser Company $WY

Janus Henderson Group PLC significantly reduced its stake in Weyerhaeuser Company by 75.1% in the first quarter, selling over 316,000 shares but still retaining holdings valued at approximately $2.57 million. Weyerhaeuser exceeded Q1 earnings estimates with an EPS of $0.13 and reported revenue of …

National Vision Holdings Inc (EYE) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for National Vision Holdings Inc (EYE), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that 12 analysts recommend a "Buy" trend for EYE, with an average price target of $35.00. The company's …

EyePoint Pharmaceuticals Inc (EYPT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for EyePoint Pharmaceuticals Inc (EYPT), highlighting its current earnings forecast score of 8.71 within the Pharmaceuticals industry. It details analyst ratings, price targets, and expected EPS and revenue figures. The forecast indicates a "Buy" trend based on analyst …

Keyera Corp. Earnings Call Highlights Growth And Synergies

Will Keyera’s Q2 Earnings Beat and Dividend Hike Change Keyera's (TSX:KEY) Narrative?

Price to earnings forward of Chaoju Eye Care Holdings Ltd. – HKEX:2219

Trading Systems Reacting to (WY) Volatility

This article analyzes Weyerhaeuser Company (NYSE: WY) volatility using AI models to generate trading strategies. It highlights a strong near-term sentiment, a mid-channel oscillation pattern, and an exceptional risk-reward short setup. The analysis provides specific entry, target, and stop-loss levels for position, momentum breakout, …

ETFs Investing in National Vision Holdings, Inc. Stocks

This article lists various ETFs that hold stocks of National Vision Holdings, Inc. (A2H5Q0). It provides detailed information for each ETF including market value, weight of the stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and …

National Vision Holdings Inc (7NV.MU) Analyst insights, Price targets and Recommendations

This article provides an overview of recent analyst activities for National Vision Holdings Inc (7NV.MU), including upgrades, downgrades, and maintained ratings from various financial institutions. The stock is currently trading at 19.60 EUR, down 2.00%. Key analysts from Citigroup, UBS, Morgan Stanley, Wells Fargo, …

Weyerhaeuser (WY) Stock Looks Cheap On Cash Flow But Pricey On Earnings

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Weyerhaeuser stock has delivered a decline of about 15.1% over the past three years, yet current valuation checks suggest the shares now sit …

Weyerhaeuser (WY) Could Be 18% Undervalued After Stronger Second Quarter Earnings

Weyerhaeuser (WY) recently reported strong second-quarter 2026 earnings, with net income of US$162 million and earnings per share of US$0.23, leading to short-term stock gains. Despite these positive developments, Simply Wall St suggests the stock could still be 18% undervalued, with a fair value …

Earnings Preview: HawkEye 360 to Report Financial Results Post-market on August 13

This article announces that HawkEye 360 will report its financial results post-market on August 13. It is an earnings preview indicating an upcoming financial disclosure by the company.